Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × larotrectinib × Tumor-Agnostic × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Thoracic 1 Sarcoma 1 Other solid neoplasm 1 Head & Neck 1 Gastrointestinal 1 Dermatologic 1 Breast 1

Conditions

Interventions

trastuzumab deruxtecan 1 pembrolizumab 1 margetuximab 1 lenvatinib 1 larotrectinib 1 atezolizumab 1 Trastuzumab 1 Pemetrexed 1 Carboplatin 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02637687 2025-06-22

SCOUT

Bayer

Phase 1/2 Active not recruiting

154 enrolled 3 FDA

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡